Loading company…
Strata Oncology, Inc., based in Ann Arbor, develops predictive biomarker scores that guide cancer treatment decisions.
Founded in 2015 and based in Ann Arbor, US, Strata Oncology, Inc. develops predictive biomarker solutions for precision oncology, including the Antibody Drug Conjugate Treatment Response Score and the Immunotherapy Response Score. Clients include biopharmaceutical companies and healthcare providers, who pay for access to the scores. The company has raised funding over three rounds, most recently a USD 90.00 mn Series C in July 2021 led by Wellington Management; founders are Dan Rhodes and Scott Tomlins.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in